Clofarabine induces ERK/MSK/CREB activation through inhibiting CD99 on Ewing sarcoma cells.
Clofarabine, an FDA approved purine analog, is used in the treatment of relapsed or refractory acute lymphoblastic leukemia. Clofarabine acts by inhibiting DNA synthesis. We demonstrated that clofarabine may have a novel function though inhibiting CD99, a transmembrane protein highly expressed on Ew...
Guardado en:
Autores principales: | Handan Sevim, Haydar Çelik, Levent Düşünceli, Ceyda S Ceyhan, Anna Molotkova, Kay Nakazawa, Garrett T Graham, Jeffrey R Petro, Jeffrey A Toretsky, Aykut Üren |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e9183073007d4d23ac98366b8bb127d1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Use of clofarabine for acute childhood leukemia
por: A Pession, et al.
Publicado: (2010) -
Older Adult Use and Outcomes in a Digital Musculoskeletal (MSK) Program, by Generation
por: Grace Wang, et al.
Publicado: (2021) -
The Impact of Reassurance on Musculoskeletal (MSK) Pain: A Qualitative Review
por: Lok Cheung, et al.
Publicado: (2021) -
ESTIMATION OF NEWER ANTI-CANCER DRUG CLOFARABINE IN THEIR PHARMACEUTICAL DOSAGE FORM BY STABILITY INDICATING TLC METHOD
por: Patel,Brijesh, et al.
Publicado: (2018) -
miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy
por: Shawn S. Badal, et al.
Publicado: (2016)